Eurofins Discovery has supported Drug Discovery research for >40 years. We offer a complete, single-source solution for drug discovery products and services and are rooted in the deep expertise and best-in-class offerings of 6 premier CROs: Cerep, DiscoverX, EMP Millipore Drug Discovery Solutions, Panlabs, Selcia Drug Discovery, and Villapharma. Eurofins Discovery can optimize your process – whether you need complete, end-to-end services, help with one or more stages, or the products for discovery work.

The Eurofins Discovery team was built by bringing together the market-leading discovery expertise of Panlabs (acquired in 2012 from Ricerca), Cerep (acquired in 2013), EMD Millipore’s Discovery & Development Solutions business (acquired from Merck KGaA in 2014), Villapharma Research (acquired in 2017), DiscoverX (acquired 2017), and Selcia Drug Discovery (acquired 2018). With over 600 people in seven operational sites worldwide: St. Charles, MO (USA), Fremont, CA (USA), San Diego, CA (USA), Essex (UK), Celle Lévescault (France), Taipei (Taiwan), and Murcia (Spain) our global team offers the high quality, reliable solutions and support our clients depend on to advance their drug discovery programs

Combining our broad, high quality, industry-leading drug discovery products & services portfolios together enables us to support our global clients with one of the industry’s largest and broadest portfolios.